fbpx Skip to main content

Member's Profile


332 Encinitas Blvd Ste 102
Encinitas,   California
United States
Membership Info
Membership Type: Industry
Membership Since: 2019
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About Okogen
Biotech Company
Okogen is a clinical-stage, specialty biotechnology company focused on developing therapeutics to help patients with ocular diseases. The company’s lead development candidate, OKG-0301, is a broad-spectrum antiviral that functions intracellularly to inhibit viral replication and reduce inflammation. These mechanisms of action are expected to provide clinical benefit in addressing adenoviral infections of the eye as well as other classes of viruses that are active in the ocular space, including herpes simplex virus, varicella-zoster virus, picornavirus, and more.
Related News
No related news posted by this Member